Article

Sydney Morning HeraldSydney Morning Herald on 2018-01-31 08:17

Major Sirtex investor backs ''compelling" $1.6 billion bid

A looming class action is unlikely to stop the proposed $1.6 billion takeover of biotech company Sirtex by US cancer care firm Varian, but a higher ...

Related news